Measuring T-Cell Response to SARS-CoV-2 Using Elecsys IGRA SARS-CoV-2 Assay

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Purpose

This study aims to assess T-cell response in individuals with a previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (COVID-19) vaccination using the Elecsys ® IGRA SARS-CoV-2 assay that is designed to detect broad-spectrum T-cell response. Preliminary data show that SARS-CoV-2 can elicit a robust and durable T-cell response, which, in conjunction with antibody response, may contribute to infection control. Furthermore, studies have shown that T-cell response is not substantially affected by emerging variants. The Elecsys IGRA SARS-CoV-2 assay combines in vitro T-cell stimulation and an automated electrochemiluminescence immunoassay for interferon-γ measurement to qualitatively detect T-cell-mediated response to SARS-CoV-2 in human whole blood.

Methods

Clinical sensitivity of the Elecsys IGRA SARS-CoV-2 assay in convalescent and vaccinated adults was evaluated in a prospective clinical study including two cohorts in Germany, while specificity was determined in participants who were unvaccinated, without prior knowledge of a SARS-CoV-2 infection, and non-reactive to the Elecsys Anti-SARS-CoV-2 and Elecsys Anti-SARS-CoV-2 S serology assays.

Results

The Elecsys IGRA SARS-CoV-2 assay showed high sensitivity and specificity in detecting SARS-CoV-2-elicited T-cell response. The Elecsys IGRA SARS-CoV-2 assay was found to reliably detect T-cell response upon natural infections or vaccinations, with sensitivity exceeding 99%, which was maintained up to 307 days following the last dose of the vaccine and up to 736 days post-symptom onset.

Conclusion

Measuring T-cell response in convalescent and vaccinated individuals is feasible and can be meaningful in providing a more complete picture of the immune status of individuals in conjunction with serology assays.

Article activity feed